Zepbound Lowers Heart Attack, Stroke Risk Among Type 2 Diabetics

MONDAY, Aug. 10, 2026— The weight loss drug Zepbound might cut the risk of heart attack or stroke among type 2 diabetics with excess weight and heart problems, a new study says.Patients taking tirzepatide (Zepbound/Mounjaro) had a 32% lower risk...